Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.
Ohira M, Oba S, Nakamura Y, Isogai E, Kaneko S, Nakagawa A, Hirata T, Kubo H, Goto T, Yamada S, Yoshida Y, Fuchioka M, Ishii S, Nakagawara A.
Ohira M, et al. Among authors: nakagawa a.
Cancer Cell. 2005 Apr;7(4):337-50. doi: 10.1016/j.ccr.2005.03.019.
Cancer Cell. 2005.
PMID: 15837623
Free article.